How much funding has Uncommon Bio raised?

Uncommon Bio has raised $6.0M in total funding, most recently a Seed round.

When was Uncommon Bio founded?

Uncommon Bio was founded in 2017.

Where is Uncommon Bio headquartered?

Uncommon Bio is headquartered in Cambridge, United Kingdom.

What industry is Uncommon Bio in?

Uncommon Bio operates in Biotech, Healthcare.

How many employees does Uncommon Bio have?

Uncommon Bio has 11-50 employees.

Uncommon Bio

Closed

Cambridge, United Kingdom · Founded 2017 · $6.0M raised

Biotech

Healthcare

Headquarters: Cambridge
Employees: 11–50
Founded: 2017
Business Model: B2B

Website: uncommonbio.co
Total Funding: $6.0M
Last Round: $6.0M SeedMay 2026
Rounds: 1

About

Uncommon Bio (formerly Higher Steaks) was a Cambridge, UK-based food biotech company founded in 2017, pioneering cultivated meat and RNA delivery technologies. After selling its cultivated meat platform to Meatable in August 2025, the company pivoted to RNA therapeutics and relaunched as SymphoRNA. The entity is effectively closed as Uncommon Bio.

Summary

Uncommon Bio is a Biotech company based in Cambridge, United Kingdom, founded in 2017. It has raised $6.0M in total across 1 round, most recently a $6.0M Seed round in May 2026.

LinkedIn X (Twitter)